160 related articles for article (PubMed ID: 34444675)
1. The Role of Vitamin K in Cholestatic Liver Disease.
Sultana H; Komai M; Shirakawa H
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444675
[TBL] [Abstract][Full Text] [Related]
2. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
[TBL] [Abstract][Full Text] [Related]
3. Xenobiotic-sensing nuclear receptors CAR and PXR as drug targets in cholestatic liver disease.
Kakizaki S; Takizawa D; Tojima H; Yamazaki Y; Mori M
Curr Drug Targets; 2009 Nov; 10(11):1156-1163. PubMed ID: 19925451
[TBL] [Abstract][Full Text] [Related]
4. Rifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets.
Guthrie G; Stoll B; Chacko S; Lauridsen C; Plat J; Burrin D
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G41-G52. PubMed ID: 31604032
[TBL] [Abstract][Full Text] [Related]
5. Schisandrol B protects against cholestatic liver injury through pregnane X receptors.
Zeng H; Jiang Y; Chen P; Fan X; Li D; Liu A; Ma X; Xie W; Liu P; Gonzalez FJ; Huang M; Bi H
Br J Pharmacol; 2017 Apr; 174(8):672-688. PubMed ID: 28128437
[TBL] [Abstract][Full Text] [Related]
6. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice.
Fan S; Liu C; Jiang Y; Gao Y; Chen Y; Fu K; Yao X; Huang M; Bi H
J Ethnopharmacol; 2019 Dec; 245():112103. PubMed ID: 31336134
[TBL] [Abstract][Full Text] [Related]
7. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
8. Pregnane X receptor as a therapeutic target for cholestatic liver injury.
Lan H; Zhang Y; Fan M; Wu B; Wang C
Drug Metab Rev; 2023 Nov; 55(4):371-387. PubMed ID: 37593784
[TBL] [Abstract][Full Text] [Related]
9. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
[TBL] [Abstract][Full Text] [Related]
10. Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism.
Bhalla S; Ozalp C; Fang S; Xiang L; Kemper JK
J Biol Chem; 2004 Oct; 279(43):45139-47. PubMed ID: 15322103
[TBL] [Abstract][Full Text] [Related]
11. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.
Xie W; Radominska-Pandya A; Shi Y; Simon CM; Nelson MC; Ong ES; Waxman DJ; Evans RM
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3375-80. PubMed ID: 11248086
[TBL] [Abstract][Full Text] [Related]
12. Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor.
Kliewer SA; Willson TM
J Lipid Res; 2002 Mar; 43(3):359-64. PubMed ID: 11893771
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription.
Li T; Chiang JY
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G74-84. PubMed ID: 15331348
[TBL] [Abstract][Full Text] [Related]
14. Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis.
Kim KH; Choi JM; Li F; Arizpe A; Wooton-Kee CR; Anakk S; Jung SY; Finegold MJ; Moore DD
Endocrinology; 2018 Jun; 159(6):2435-2446. PubMed ID: 29718219
[TBL] [Abstract][Full Text] [Related]
15. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
Zollner G; Marschall HU; Wagner M; Trauner M
Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
[TBL] [Abstract][Full Text] [Related]
16. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
Guo GL; Lambert G; Negishi M; Ward JM; Brewer HB; Kliewer SA; Gonzalez FJ; Sinal CJ
J Biol Chem; 2003 Nov; 278(46):45062-71. PubMed ID: 12923173
[TBL] [Abstract][Full Text] [Related]
17. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.
Trauner M; Wagner M; Fickert P; Zollner G
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S111-24. PubMed ID: 15758646
[TBL] [Abstract][Full Text] [Related]
18. Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasis.
Gabbia D; Pozza AD; Albertoni L; Lazzari R; Zigiotto G; Carrara M; Baldo V; Baldovin T; Floreani A; Martin S
World J Gastroenterol; 2017 Nov; 23(42):7519-7530. PubMed ID: 29204052
[TBL] [Abstract][Full Text] [Related]
19. Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis.
Teng S; Piquette-Miller M
Br J Pharmacol; 2007 Jun; 151(3):367-76. PubMed ID: 17435798
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of vitamin K deficiency in children with mild to moderate chronic liver disease.
Mager DR; McGee PL; Furuya KN; Roberts EA
J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):71-6. PubMed ID: 16385257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
